BRD9 and neoplasm: When castrated mice bearing C4-2B with BRD9 overexpression or not were treated with CP-320626, the BRD9-induced increase of tumor growth was significantly inhibited, as shown by tumor growth, tumor volume, and the proliferation index Ki67 (Fig. S7C–F).